Zovighian Bernard J
CEO
Zovighian Bernard J has filed 7 SEC Form 4 filings (30 transaction rows) across 1 company, with disclosures dating back to 2025. 7 of those filings fall inside the rolling window. Most recent filing: Jul 27, 2026.
On the most recent filing, Zovighian Bernard J is listed as CEO at Edwards Lifesciences Corp. Inside the rolling window, Zovighian Bernard J reported no open-market purchases and 6 open-market sales totaling $7.0M in EW. The largest disclosed transaction in the window is a sale of 36,351 EW shares on May 12, 2026, worth $2.8M.
Companies traded
Other insiders at EW
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.0M
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Zovighian Bernard J made?
Zovighian Bernard J has filed 7 SEC Form 4 filings (30 transaction rows) across 1 company since 2025.
Which companies does Zovighian Bernard J trade?
Zovighian Bernard J has filed SEC Form 4 disclosures for 1 company, including EW.
When was Zovighian Bernard J's most recent SEC Form 4 filing?
Zovighian Bernard J's most recent SEC Form 4 filing on Tracefour is dated Jul 27, 2026.
What is Zovighian Bernard J's job title?
On the most recent SEC Form 4 filings tracked by Tracefour, Zovighian Bernard J is listed as CEO.
What is Zovighian Bernard J's total buy and sell value in the current window?
Inside the rolling retention window, Zovighian Bernard J bought $0 and sold $7.0M based on SEC Form 4 filings.
What was Zovighian Bernard J's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 36,351 EW shares on 2026-05-12, worth $2.8M, per SEC Form 4 filings.